10366466 · Active · incorporated 10 years, 1 month ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Sitryx Therapeutics is a biotechnology company focused on developing novel immune therapies for autoimmune and inflammatory diseases.
Sitryx is a private limited company registered at Companies House under number 10366466, incorporated on 8 September 2016, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 100 filings for this company, including 5 funding rounds. Its most recent round closed in May 2025, raising £12m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 5 | May 2025 | £12m | £1.90 |
| Round 4 | Sep 2023 | £20m | £1.90 |
| Round 3 | Jan 2023 | £4.7m | £1.90 |
| Round 2 | Apr 2020 | £15.7m | £1.90 |
| Round 1 | Feb 2018 | £12m | £1.45 |
Showing the 10 most recent of 100 filings.
See the complete cap table with every shareholder, founder tags, dilution across 25 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.